【作者】 张延伟； 苌英利； 薛春晓； 曹喜才； 李建华； 李斌； 徐晓冉；

【Author】 ZHANG Yan-wei, CHANG Ying-li, XUE Chun-xiao, CAO Xi-cai, LI Jian-hua, LI Bin, XU Xiao-ran (Department of Radiology, the First Affiliated Hospital of Guangzhou University of TCM, Guangzhou 510405, China)

【机构】 广州中医药大学第一附属医院放射科； 河北石家庄钢铁股份有限公司职工医院； 天津医科大学总医院；

【摘要】 目的　探讨介入治疗在肝肾肿瘤合并布 加综合症中的应用价值。方法　肝癌3例,肾癌1例。行单纯溶栓1例,PTA成形术3例,PTA后再植入国产“Z”形自膨胀支架2例。结果　术后DSA检查原侧枝循环血流明显减少。术后一周左右,患者的症状和体征改善明显。术后6个月彩超随访显示支架均开通良好。结论　血管内溶栓和支架植入术是继发性BCS的首选姑息治疗方法,可延长患者生存时间,提高生存质量更多还原

【Abstract】 Objection To study the role of interventional therapy in patients with Budd-Chiari Syndrome (BSC) following liver cancer or renal cancer. Methods There were 3 liver cancers and 1 renal cancer. We administrated simple thrombolysis in 1 case, percutaneous transluminal angioplasty (PTA) in 3 cases, and PIA+self-expansion stent in 2 cases. Results Collateral circulations were obvionsly reduced after interventional therapy. The signs and symptoms of patients were significantly improved in 1 week. Colorful ultrasound examination showed all stents were still keeping open after 6 months. Conclusion The first therapy of secondary BCS following hepatic or renal tumors were thrombolysis and/or percutanous transcatheter stent placement,which can extend survival and improve the quality of patients.更多还原